| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $84.1M | +2.8% | +17.2% |
| Cost of Revenue | $48.6M | +2.5% | +8.0% |
| Gross Profit | $35.5M | +3.1% | +32.7% |
| R&D Expense | $13.9M | +2.8% | +17.6% |
| SG&A Expense | $23.3M | -11.6% | +11.4% |
| Operating Income | -$15.3M | +22.1% | +10.1% |
| Pre-tax Income | -$7.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $117.6M | +33.9% | +102.7% |
| Accounts Receivable | $71.2M | -7.8% | +24.2% |
| Current Assets | $507.4M | +18.3% | +55.4% |
| Total Assets | $1.21B | +1.2% | -1.6% |
| Current Liabilities | $72.4M | +1.5% | -2.1% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$23.5M | — | — |
| Capital Expenditures | $17.6M | — | — |
| Investing Cash Flow | $100.2M | — | — |
| Financing Cash Flow | -$14.3M | — | — |
| Free Cash Flow | -$41.1M | — | — |
| +65.1% |
| +59.5% |
| Income Tax | -$683K | +69.8% | +82.2% |
| Net Income | -$6.6M | +65.1% | +54.9% |
| $93.8M |
| +6.4% |
| -5.1% |
| Stockholders' Equity | $1.13B | +0.8% | -1.1% |